| Literature DB >> 27350777 |
Keiichi Kumai1, Kenichi Meguro1, Mari Kasai1, Kei Nakamura1, Masahiro Nakatsuka1.
Abstract
BACKGROUND: Recently, the concept of motoric cognitive risk (MCR) syndrome was proposed, where slow gait is considered a risk factor for conversion to dementia. AIM: To retrospectively investigate the characteristics of MCR among a population aged 75+ years, focusing on the aspects of epidemiology and neurobehavioral characteristics.Entities:
Keywords: Executive function; Gait; Motoric cognitive risk syndrome
Year: 2016 PMID: 27350777 PMCID: PMC4913768 DOI: 10.1159/000445539
Source DB: PubMed Journal: Dement Geriatr Cogn Dis Extra ISSN: 1664-5464
Fig. 1A total of 590 residents from among the 1,254 people aged 75+ years living in Kurihara participated in the study and underwent MRI and neurobehavioral assessments, including walking velocity. Possible subjects with MCR syndrome were in the CDR 0 or 0.5 groups; 474 people with CDR 0 or 0.5 were followed up for 3-5 years.
Rates of conversion to dementia
| Entry cases | Incidence cases | Person-years (3–5 years) | Incidence rate/1,000, %0 | |
|---|---|---|---|---|
| MCR group | 35 | 15 | 125.2 | 119.8 |
| Non-MCR group | 264 | 88 | 858.8 | 102.5 |
Assessment of dementia is based on the AD8.
Incidence rate/1,000 = (number of incidence cases/person-years) × 1,000.
Neurobehavioral characteristics
| MCR group | Non-MCR group | p value | |
|---|---|---|---|
| Subjects (men/women) | 57 (19/38) | 456 (181/275) | |
| Age, years | 80.4 (4.3) | 79.7 (4.0) | 0.25 |
| Education, years | 8.0 (1.0) | 9.0 (2.0) | <0.001 |
| MMSE score | 22.8 (3.5) | 24.1 (3.3) | 0.01 |
| TMT-A score | 92.6 (34.8) | 74.7 (28.8) | <0.001 |
| Digit symbol 120 s score | 25.9 (9.3) | 31.8 (11.5) | <0.001 |
| Gait velocity, m/s | 0.8 (0.1) | 1.2 (0.3) | <0.001 |
Significant by one-way ANCOVA with the covariate of MMSE.
Neurological background
| CDR 0 | CDR 0.5 | |||
|---|---|---|---|---|
| very mild AD | very mild SVD | other CDR 0.5 | ||
| MCR group | 2/9 | 5/8 | 2/3 | 6/15 |
| Non-MCR group | 31/129 | 17/44 | 12/26 | 28/65 |
Incidence rate/total baseline number in the incidence study of 2013.